Recently, researchers conducted a study to examine whether the presence of rheumatoid arthritis affected the risk of developing chronic obstructive pulmonary disease or asthma, independent of lifestyle...
The US Food and Drug Administration recently approved the first single dose once-daily inhaler to be used as maintenance therapy for patients with chronic obstructive pulmonary disease.
In 2 recent studies, researchers examined the safety and efficacy of adding mepolizumab to triple therapy in patients with COPD and an eosinophil phenotype.
In 2 recent studies, researchers examined the safety and efficacy of adding mepolizumab to triple therapy in patients with COPD and an eosinophil phenotype.
Patients with mild to moderate chronic obstructive pulmonary disease rarely receive medications, since they typically have few symptoms. In a recent study, researchers assessed the effects of long-term use...
Patients with mild to moderate chronic obstructive pulmonary disease rarely receive medications, since they typically have few symptoms. In a recent study, researchers assessed the effects of long-term use...
Few studies have compared the effects of once-daily triple therapy with twice-daily dual therapy for COPD. In a recent study, researchers more thoroughly compared these treatments.
Few studies have compared the effects of once-daily triple therapy with twice-daily dual therapy for COPD. In a recent study, researchers more thoroughly compared these treatments.
In a recent study, researchers investigated the effects of continuous positive airway pressure and adaptive servo-ventilation on rates of cardiovascular events and death in this population.
